Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
Broad Institute · Brigham and Women's Hospital · +6 more institutions
Abstract
UNLABELLED: The CRISPR/Cas9 system enables genome editing and somatic cell genetic screens in mammalian cells. We performed genome-scale loss-of-function screens in 33 cancer cell lines to identify genes essential for proliferation/survival and found a strong correlation between increased gene copy number and decreased cell viability after genome editing. Within regions of copy-number gain, CRISPR/Cas9 targeting of both expressed and unexpressed genes, as well as intergenic loci, led to significantly decreased cell proliferation through induction of a G2 cell-cycle arrest. By examining single-guide RNAs that map to multiple genomic sites, we found that this cell response to CRISPR/Cas9 editing correlated…
Citation impact
- FWCI
- 46.13
- Percentile
- 100%
- References
- 48
Authors
30- AJAndrew J. Aguirre
Broad Institute, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute
- RMRobin M. Meyers
Broad Institute
- BABarbara A. Weir
Broad Institute, Dana-Farber Cancer Institute
- FVFrancisca Vázquez
Broad Institute, Dana-Farber Cancer Institute
- CZCheng‐Zhong Zhang
Broad Institute, Dana-Farber Cancer Institute
Topics & keywords
- CRISPR
- Biology
- Genome editing
- Cas9
- Gene
- Genetics
- Computational biology
- Genome
- Good health and well-being